Pharma continues to hire consumer executives for digital transformation and acceleration

Rau most recently headed information technology for Apple’s retail and online stores. He worked at Apple for 10 years, developing its online and retail store technology including the e-commerce platform, mobile point of sale, online store app and internal systems used by retail store employees.

Lilly’s move to hire a consumer veteran comes at a turning point in pharma's digital adoption. Now more than a year into the pandemic, the initial scramble to shift to digital technologies across business units is beginning to settle in.

Lilly CEO David Ricks said Rau’s experience at Apple “will be invaluable to Lilly as we change how we discover, develop, manufacture and commercialize innovative new medicines."

Lilly joins the ongoing pharma trend over the past four years hiring former consumer company digital leaders.

Sanofi hired its chief digital officer Arnaud Robert last year from Viking Cruises, where he held the same role.

GlaxoSmithKline was one of the first to hire from the consumer world when it recruited a former executive from Walmart.

Novartis hired its first chief digital officer in 2018 from a career in retail that included Amazon and EMI Music.

However, not all the consumer-to-pharma executive hires have stuck.

Merck & Co. tapped Jim Scholefield as chief information and digital officer in 2018, but the former Nike executive left last year to return to consumer digital at Marriott. Marc Speichert recently left GlaxoSmithKline, where he had served for four years as the chief digital officer for its consumer health business. He is now the chief commercial officer at Four Season Hotels and Resorts.

 

Based on this article.

RECENT POSTS

The Transformational Impact of Artificial Intelligence on the Patient-Physician Relationship

In today’s ever-evolving healthcare landscape, the integration of artificial intelligence (AI) has ushered in a new era of possibilities, presenting…

What is Medical Communications? The definitive guide.

Medical Communications. The demand for clear and integrated dissemination of scientific knowledge is critical for the Pharmaceutical industry. Medical communications—or…

Enhancing engagement with healthcare professionals (HCPs): How AI is transforming Pharma relationships.

Pharmaceutical companies are progressively turning to the use of Artificial Intelligence (AI) as a tool to transform several aspects of…

Six communication trends Pharma needs to watch in 2024.

As we approach 2024, the Pharma industry’s focus on developing and maintaining meaningful relationships with healthcare professionals (HCPs) will only…

The EU Artificial Intelligence Act: A New Era of Regulation 
The EU's proposed AI Act, the world's first comprehensive legal framework for AI, is set to revolutionize global AI regulation. Learn about its risk classification levels and the potential implications for the Life Sciences industry.
0 +

YEARS IN

MARKET

0 +

THERAPY

AREAS

WORK IN

0 +

COUNTRIES


GET IN TOUCH

Whether you’re looking for effective solutions to transition F2F meetings to a virtual or online environment, support with clinical trials, medical advisory boards, symposia, key opinion leader (KOL) management, internal medical training, medical writing or speaker training programs and more, count on our 16-year experience and expertise over 40 therapeutic areas.

SDM also offers strategic consulting services and can help with communication and engagement of your target audiences as part of market development opportunities.

Discover why over 95% of clients are “Extremely Satisfied” with SDM and over 90% say the agency deliver “Much more than expected”.